Bovine Respiratory Disease
How stress, vaccination timing and product choice influence respiratory disease prevention in young calves.
Post-treatment interval decisions may shape both clinical outcomes and antimicrobial stewardship in bovine respiratory disease protocols.
A trusted adjuvant can make all the difference in capturing a strong immune response in young calves.
A comprehensive herd-health program is crucial for the management and prevention of bovine respiratory disease.
K-State veterinarian Bob Larson says 3% to 5% of calves suffer from pnemonia each year.
Looking at Mycoplasma Bovis in beef herds including a calf’s environment and vaccination program.
Experts at Kansas State University’s Beef Cattle Institute share guidelines for tracking herd health.
Feedlot owners and cow-calf producers can use best practices for helping those cattle get off to a good start when entering the yard.
Looking below the tip of the iceberg is helping the beef industry better understand and address root causes of health problems in populations of cattle.
Dr. John Groves says a holistic approach is a good way to address chronic, challenging problems in a population of cattle rather than treating individual animals only.
Dr. Brad White is building a multi-disciplinary team to research the issue. The team will sample over 2,400 cattle in Kansas and Texas as part of their work.
While new technologies are in development to help diagnose BRD, for now the best tool is a trained human eye.
A team at K-State has been chosen by the World Organisation of Animal Health to lead an international effort that will develop decision-making tools and improve communication on the economic impacts of animal diseases.
Zelnate DNA Immunostimulant is used to treat respiratory disease due to Mannheimia haemolytica. The label recommends use at or within 24 hours after a perceived stressful event in cattle 4 months of age and older.
Drs. Grant Dewell and Mike Apley, respectively, and Extension nutritionist Paul Beck weigh in on some things they believe contribute to the disease and how you can stem its development from the farm to the feedlot.
While vaccination is widely considered a critical component of cattle health management, could the timing of vaccination impact the efficiency of the product?
SpectoGard (spectinomycin sulfate) sterile solution—which received FDA approval in September of 2022—is now available for veterinarians and cattle producers in the United States.
Depressed, feverish calves with an increased respiratory rate? Your calves are likely fighting a case of ‘summer pneumonia.’
Zoetis Draxxin KP is designed to control bovine respiratory disease and, specifically, fever.
You can take preventive steps to protect calves from bovine respiratory disease (BRD), long before you ever reach for antibiotics.
When loads of stressed, high-risk calves arrive at the feedlot, it often makes economic sense to treat them all with antibiotics to prevent an almost-inevitable outbreak of bovine respiratory disease (BRD).
Cattle feeders first began using mass treatments for newly arrived calves back in the 1970s, as a means of controlling outbreaks of respiratory disease or “shipping fever.”
Animal welfare, sustainability and economics are affected when beef cattle suffer from bovine respiratory disease, or BRD.
Research and practical experience have shown a genetic component to the ability of individual cattle, or sire lines, to resist BRD pathogens.
We need to better address all three components of the disease triad.
Assessing the risk of cattle needing treatment for bovine respiratory disease (BRD) requires consideration of far more than exposure to patahogens.
While researchers and the industry work to develop systems to better prevent BRD, timely treatments with antibiotics will remain a critical tool for minimizing losses associated with morbidity.